Related by context. All words. (Click for frequent words.) 72 Brentuximab vedotin 72 drug conjugate 67 anti CD# monoclonal 66 MT# MEDI 66 POTELLIGENT R 66 agonistic human 66 dacetuzumab SGN 65 NS5b 65 CD4 monoclonal antibody 65 BiTE R 65 Roche SWX ROG 65 Locked Nucleic Acid 65 anti CD3 monoclonal 64 human IgG1 monoclonal 64 lintuzumab SGN 64 attach auristatin 64 Micromet proprietary BiTE 64 ImmunoGen TAP technology 64 MT#/MEDI-# 64 PNP inhibitor 64 CYT# potent vascular disrupting 64 XL# XL# XL# XL# 63 Provectus Pharmaceuticals specializes 63 alpha folate receptor 63 targeting CD# 63 Inc. AMEX YMI 63 Kosan dependence 63 UltiMAb 63 oncolytic virus therapies 63 CD# CEA 63 IMA# 63 proprietary BiTE ® 63 GRNVAC1 63 non nucleoside inhibitor 63 GVAX ® 63 ASG 5ME 63 investigational immunotherapy 63 Dacetuzumab 63 MCSP respectively 63 oncolytic 62 IMC #B 62 Nycomed GmbH 62 humanized anti 62 PDE4 inhibitor 62 IAP inhibitor 62 NTDDS 62 therapeutic monoclonal antibody 62 including Cobalamin TM 62 FORMA Therapeutics 62 CDK cyclin dependent 62 Intravenous Human 62 IAP inhibitors 62 Aurora kinase inhibitor 62 mertansine 62 Jaiva Technologies 62 Allovectin 7 62 ribonucleotide reductase clinically validated 62 cathepsin K inhibitor 62 Vaccinex 62 accumulate preferentially 62 LymphoStat B TM 62 Crofelemer budesonide foam 62 Roche SIX RO 62 MAGE A3 ASCI 62 BiTE antibody 62 IMiDs R 62 HyperAcute 62 targeted radiotherapeutic 62 chimeric monoclonal antibody 62 SuperAntibody 62 AGS PSCA 62 HCV NS5B polymerase 62 M2 subunit 62 OGeS 62 Phase #b/#a clinical 62 humanized monoclonal antibody 62 Apexigen 62 BCR ABL inhibitors 62 IMiDs ® compound 61 HIV integrase inhibitor 61 Civacir TM 61 developing TB4 61 AKIP ™ 61 Epothilones 61 XL# XL# 61 oral ghrelin agonist 61 proteasome inhibitor 61 novel RNAi therapeutics 61 HCV protease inhibitor 61 AAG geldanamycin analog 61 HCD# [002] 61 GeoVax AIDS vaccine 61 tubulin inhibitor 61 HuCAL antibody 61 SinuNase ™ 61 Selective Electrochemical Tumor Ablation 61 Targeted Chemotherapy 61 5 HT6 61 Trastuzumab DM1 61 novel peptides 61 multi kinase inhibitor 61 therapeutic monoclonal antibodies 61 Potelligent Technology 61 TRANSDUR ™ 61 POTELLIGENT R Technology 61 adecatumumab MT# 61 IgG1 monoclonal antibody 61 MVA BN R 61 antibody MAb 61 OncoVEX 61 Myocet 60 recombinant subunit vaccine 60 Fresenius Biotech 60 dacetuzumab 60 trastuzumab Herceptin R 60 PORxin TM 60 EHT AGN 60 novel immunomodulatory 60 drug pipeline TAFA# 60 anticancer therapeutics 60 HuCAL 60 receptor inhibiting monoclonal 60 PORxin TM platforms 60 histone deacetylase HDAC inhibitors 60 telomerase therapeutic 60 Phase Ib clinical trials 60 NASDAQ CGEN announced 60 Epitomics 60 taxane derivative 60 humanized antibody 60 proven DuraSite ® 60 Budesonide foam crofelemer 60 product platforms AZX# 60 Pharmion Corporation 60 ZFP Therapeutics 60 Elotuzumab 60 Alfacell proprietary ribonuclease 60 PSMA ADC 60 recombinant biopharmaceutical 60 MSCRAMM ® 60 NPC 1C 60 ProEthic Pharmaceuticals 60 Kosan epothilone program 60 Scancell 60 Avila Therapeutics 60 LymphoStat B belimumab 60 LentiVector technology 60 clinical trials SGN 60 MKC# MT 60 recurrent metastatic ovarian cancer 60 Taiho Pharmaceutical 60 introduced NEUGENE 60 StromaCel Inc. 60 TESARO 60 using ImmunoGen TAP 60 Captisol ® 60 CysDisplay R 60 MorphoSys proprietary 60 PentaStaph 60 VitiGam 60 liposomal formulation 60 Kyowa Hakko Kirin 60 HuLuc# 60 polymerase inhibitor 60 Valortim TM 60 HGS ETR1 mapatumumab 60 Nanobody 60 ospemifene 60 include Altastaph TM 60 commercialize Aganocide compounds 60 small molecule glucokinase 60 sapacitabine CYC# 60 label Lipofen R 60 OncoVex 60 ArQule Kinase Inhibitor Platform 60 oral dihydropyrimidine dehydrogenase DPD 60 GlaxoSmithKline Biologicals GSK 60 lipid nanoparticle 60 metabolomics driven 60 dasatinib Sprycel ® 60 HuCAL PLATINUM ® CysDisplay 60 & LSE GLPG 60 vinca alkaloid 60 Seattle Genetics 59 PROfusion 59 SEQureDx ™ 59 Nanobody R 59 Litx 59 Elvitegravir 59 mitogen activated ERK kinase 59 proprietary capillary aerosolization 59 GVAX R 59 YONDELIS 59 OTCBB HXBM developer 59 Innovive Pharmaceuticals 59 VentiRx 59 4SC AG ISIN DE# 59 Solazed 59 DiscoveRx 59 OncoSec Medical 59 MMAE 59 personalized cellular immunotherapy 59 MKC# MKC# PP 59 HuCAL GOLD R 59 Sangamo ZFP technology 59 SCIB1 59 INxin TM 59 Dyax phage display 59 commercialize becocalcidiol patented 59 MEK inhibitor 59 HepaMate ™ 59 HCV polymerase 59 personalized dendritic cell 59 small molecule thrombopoietin 59 candidates Azedra TM 59 systemic RNAi therapeutic 59 drug conjugates 59 IMiDs ® 59 PI3K/Akt pathway inhibitor 59 PHX# 59 XL# anticancer compounds 59 orally administered inhibitor 59 developing Zerenex ferric 59 OTCBB PYTO 59 HGS ETR2 59 androgen receptor antagonist 59 ATRA IV 59 HuMax TAC 59 UVIDEM 59 Antibody Drug Conjugate 59 AEG# 59 non nucleoside polymerase 59 Ixabepilone 59 Epothilone D 59 rxRNA 59 refractory chronic lymphocytic 59 pralatrexate injection folate analogue 59 apricitabine ATC 59 epothilone 59 Japanese drugmaker Daiichi 59 Protexia ® 59 cleavable linker 59 BioNumerik 59 Veronate R 59 ImmunoGen maytansinoid TAP 59 nicotinic alpha 7 59 selective immunoproteasome inhibitor 59 Agensys subsidiary 59 BioInvent 59 PDL# 59 Cobalamin TM mediated 59 SinuNase TM 59 Atripla combines 59 Nasdaq XTLB 59 HuCAL PLATINUM 59 TLR9 agonist 59 TKB# 59 ActivX 59 Immunotope 59 candidate custirsen 59 BiTE ® 59 evaluating tivozanib 59 Peggy Pinkston 59 Galenea 59 IgG1 antibody 59 Albuferon albinterferon alfa 2b 59 OncoSec 59 Epiphany Biosciences 59 compound KOS 59 NASDAQ SGEN 59 BioFocus DPI Galapagos 59 Tarmogen 59 histone deacetylase HDAC 59 retinoic acid receptor 59 MEK Inhibitor 59 developing adecatumumab 59 Anticalin 59 Virulizin ® 59 Etubics 59 Aphios Corporation 59 Tumor Activated Prodrug TAP 59 Cellgate 59 stable nucleic acid 59 Daclizumab 59 Potelligent TM Technology 59 poly ADP ribose polymerase 59 FOLOTYN ® 59 Inc. www.micromet inc.com 59 Through Glycoscience R 59 Fovea Pharmaceuticals subsidiary 59 leading oral taxane 58 REGN# 58 CCR5 mAb 58 metaglidasen 58 product candidate Lpathomab 58 HIV maturation inhibition 58 pan histone deacetylase 58 ADP receptor antagonist 58 XOMA 3AB 58 skeletal sarcomere activators 58 TRX1 58 Trubion proprietary 58 peptidic compound 58 Oncolys 58 DeveloGen 58 Ridaforolimus 58 R sorafenib tablets 58 virus HCV protease inhibitor 58 investigational humanized monoclonal antibody 58 immunotherapeutics 58 apoptosis proteins 58 world safest multivalent 58 JAK2 Inhibitor 58 About Positron Positron 58 P#X# antagonist 58 AFFITOME 58 Currently RegeneRx 58 pentadentate logo R 58 GlycArt 58 Cellgate Inc. 58 JAK2 inhibitor 58 MorphoSys Galapagos 58 adrenergic regulation 58 Intravenous CP 58 GenWay Biotech 58 Ii protein 58 Anticalins R 58 humanized therapeutic 58 platinum chemotherapeutic 58 novel therapeutic antibodies 58 By JAMAAL ABDUL 58 Æterna Zentaris Inc. 58 TRACON Pharmaceuticals 58 Euronext Amsterdam GLPGA 58 myelofibrosis polycythemia vera 58 Fc fusion protein 58 clinical trials dacetuzumab SGN 58 EndoTAG TM 58 miRNA therapeutics 58 Namenda Memantine HCl 58 protein kinase inhibitor 58 Anchor Therapeutics 58 DermaVir Patch 58 flu mAb 58 Advancing Drugs 58 EGFr humanized monoclonal antibody 58 FGFR 58 virus AAV 58 AB OMXS BINV 58 VEGFR2 inhibitor 58 Inc. Nasdaq INFI 58 oral Hsp# inhibitor 58 candidate deforolimus 58 immatics 58 BENLYSTA belimumab 58 Bezielle 58 Bellicum 58 Ixempra 58 triciribine phosphate monohydrate 58 * olmesartan medoxomil 58 SECTA therapy 58 HTS assay 58 bendamustine HCl 58 Endotis 58 Albugon 58 AAV vector carrying 58 mda 7 58 HIV integrase inhibitors 58 Lucanix R 58 OTCBB QTXB 58 proprietary delipidation technologies 58 Eg5 kinesin spindle 58 AKIP TM 58 anti PlGF 58 Maxy G# 58 Insegia 58 Nicotine Conjugate Vaccine 58 selective kinase inhibitor 58 auristatin E MMAE 58 Curaxin CBLC# 58 novel topoisomerase 58 selective androgen receptor modulator 58 Mersana Therapeutics 58 JAK1 58 cancer immunotherapies 58 trastuzumab DM1 T DM1 58 reslizumab 58 Pruvel ™ 58 HCV polymerase inhibitors 58 antisense drug 58 HYVISC ® treatment 58 oral proteasome inhibitor 58 alvespimycin 58 HuMax 58 Nventa proprietary CoVal 58 acid phosphatase PAP 58 AnaptysBio 58 vaccine GRNVAC1 58 Pertuzumab 58 delta opioid receptor 58 AtuRNAi 58 AMEX INO 58 therapeutic antibody 58 ADCC enhanced 58 oral prodrug 58 ganetespib 58 molecular chaperone regulation 58 anti botulism antibody 58 YONDELIS R 58 Zor Pharmaceuticals 58 Immunotherapeutic 58 lintuzumab 58 JVRS 58 visit www.genmab.com 58 entinostat 58 Expression Genetics 58 colorectal bladder 58 FivePrime Therapeutics 58 VentiRx Pharmaceuticals 58 Tumour Vascular Disrupting Agent 58 HCV NS3 protease 58 ZEVALIN ® 58 compound ITMN 58 A3 adenosine receptor 58 dasatinib Sprycel 58 SPL# Gel vaginal microbicide 58 XmAb ® 58 HCV RNA polymerase 58 commercializing Loramyc ® 58 docetaxel Taxotere R 58 Nasdaq PGNX today 58 LEAD Therapeutics 58 Astex Therapeutics Limited 58 HGS ETR1 58 Micromet BiTE 58 AVP #D# 58 candidate ridaforolimus 58 CYT# novel 58 XmAb# 58 Nasdaq OMER 58 Adenosine Therapeutics 58 kidney urologic 58 Nanobody ® 58 potent cytotoxic 58 methylnaltrexone bromide 58 candidate AQ4N 57 active AKT inhibitor 57 AVAX AC Vaccine 57 orally bioavailable 57 Monoclonal antibody 57 sorafenib tablets 57 Company Nasdaq RGDX 57 visit www.genenews.com 57 Nasdaq RGDX 57 radiation sensitizer 57 generation nucleoside analog 57 liposomal delivery 57 huC# DM4 57 HuCAL R 57 MORAb 57 HGS# 57 Nasdaq PPHM 57 using VIAdel TM 57 Cadila Pharmaceuticals named 57 prophylactic vaccines 57 cellular immunotherapy 57 candidates bavituximab 57 PEGylated interferon 57 Epigenomics proprietary 57 Vicinium TM 57 #/#/# Cytokinetics Incorporated 57 Galderma SA 57 ALN HPN 57 overactive bladder VANTAS R 57 novel antibody therapeutics 57 Aphton Corporation 57 celgosivir 57 prostone 57 monoclonal antibodies MAbs 57 developing Bicifadine serotonin 57 Cardioxyl Pharmaceuticals 57 RhuDex R 57 IMC A# 57 novel emulsion formulation 57 Solazed TM 57 RON Notch 57 CCR9 antagonist 57 anionic backbone 57 AcryMed Incorporated 57 investigational oral inhibitor 57 SAR# [002] 57 aptamer therapeutics 57 investigational monoclonal antibody 57 Zalypsis 57 Epeius Biotechnologies Corporation 57 Pneumocystis pneumonia PCP 57 rusalatide acetate 57 Staphylococcus aureus Immune Globulin 57 HSP# inhibitor 57 Aflibercept 57 Nasdaq CGEN 57 seliciclib CYC# 57 Phenomix Corporation 57 apaziquone 57 Inc. Nasdaq SGXP 57 Ceflatonin R 57 immunosuppressive compound 57 product Fentanyl TAIFUN 57 diabetes irritable bowel 57 Angiocept 57 Belimumab 57 Inc. Nasdaq IMGN 57 Prodarsan R 57 R Abelcet 57 AMEX RGN 57 Catalyst Biosciences 57 gastro intestinal inflammation 57 intravesical infusion therapy 57 intranasal formulation 57 brentuximab vedotin SGN 57 Uvidem 57 Tarvacin TM 57 Genpathway 57 ALN TTR 57 Amigal TM 57 oral ridaforolimus 57 Canvaxin TM 57 PsychoGenics 57 staphylococcal vaccines 57 OGAP R 57 developing ACAPODENE 57 Septin9 biomarker 57 Biomerix Corporation 57 ARRY # 57 antisense inhibitor 57 platforms GVAX 57 investigational compounds 57 hyaluronidase enzyme 57 Nutra Pharma wholly owned 57 XmAb 57 Genasense oblimersen sodium Injection 57 TransVax TM 57 5 lipoxygenase activating 57 NCCTG 57 Raven Biotechnologies 57 Affilin ® 57 Zolinza 57 telomerase inhibitor drug 57 isoform selective 57 OncoMed 57 dermatology gastroenterology 57 RAS MAPK pathway 57 Glufosfamide 57 compound perifosine 57 evaluating T DM1 57 RNA antagonists 57 c Raf kinase 57 orally bioavailable mimics 57 Trubion Pharmaceuticals 57 Nanobodies 57 VaxImmune 57 candidate XP# 57 Marqibo TM 57 proprietary PEGylation 57 Graffinity 57 PF # [002] 57 Tiuxetan 57 LEX System 57 Cardium Therapeutics TM 57 epothilones 57 initiated Phase 1b 57 targeted anticancer biopharmaceuticals 57 commercialize deforolimus 57 SparVax ™ 57 non nucleoside HCV 57 vapreotide acetate 57 TELINTRA R 57 ABL inhibitor 57 commercialize Aganocides 57 synthetic retinoid 57 Nasdaq ALNY 57 Zacharon 57 erlotinib Tarceva R 57 Durata Therapeutics 57 Idec Roche Takeda 57 hepatitis C HCV 57 receptor tyrosine kinase inhibitor 57 anti CD# antibodies 57 small molecule Hedgehog 57 cancer indications bafetinib 57 Aplidin R 57 DsiRNA pharmaceuticals 57 Novosom 57 delivered RNAi therapeutic 57 Clovis Oncology 57 Empatic ™ 57 cilengitide 57 JAK inhibitors 57 progressive metastatic prostate 57 Sapacitabine 57 developing Zerenex TM 57 ESPRIT therapy 57 Phase 1b clinical trials 57 tests miRview TM 57 OncoGenex Technologies 57 SAR# [004] 57 Vegenics 57 Modified Vaccinia Ankara MVA 57 forodesine 57 Agensys 57 OTCQX RHHBY 57 oncolytic virus 57 pharmacogenomic translational research 57 PKC# 57 ALN VSP 57 Pradefovir 57 VQD 57 HIV protease inhibitor 57 topical antifungal product 57 RhuDex ® 57 Cellerant 57 SIX RO ROG 57 Additionally Soligenix 57 immunotherapeutic 57 PRNewswire FirstCall Isis Pharmaceuticals 57 ELADUR ™ 57 JAK3 57 novel VDA molecule 57 AnGes 57 Tibotec BVBA 57 Protexia R 57 midstage studies 57 Merrimack Pharmaceuticals 57 dimebon latrepirdine 57 DepoCyt ® Abelcet ® 57 Ophthotech 57 targeting Inflammatory Bowel 57 RIGScan CR 57 OMP #M# 57 Pharma Merck Serono 57 Vitamin D analogue 57 EnVivo Pharmaceuticals 57 GSK '# 57 Blinatumomab 57 successfully commercialize Iluvien 57 dSLIM 57 TLR7 agonist 57 volociximab 57 commercialize Dimebon 57 Abiraterone acetate 57 ENMD # 57 autologous cellular immunotherapy 57 DOS# 56 TransVax tm 56 essential thrombocythemia ET 56 Trubion Pharmaceuticals TRBN 56 Trubion Pharmaceuticals Inc. 56 PrevOnco 56 Prednisporin 56 Aeolus Pharmaceuticals 56 Onalta 56 TRANSDUR ® 56 Amrubicin 56 Receptors GPCRs 56 Telik logo TELINTRA 56 refractory metastatic 56 include VALSTAR TM 56 Regulus Therapeutics 56 OncoVEX GM CSF 56 MAXY G# 56 Immunomedics Inc 56 ThermoDox R 56 TGR5 56 acne impetigo 56 dependent kinase inhibitor 56 Nexavar ® 56 glucokinase activator 56 specific CCR9 antagonist 56 antiangiogenesis therapies 56 MGd 56 Fludara ® 56 histone deacetylase inhibitor 56 sunitinib Sutent ® 56 Cenomed 56 XTLbio 56 Caprion 56 Intellikine 56 unique alkylating agent 56 EndoTAG 56 Peginterferon alfa 2b 56 HuCAL antibodies 56 Syncria 56 HepaMate 56 OMP #R# 56 staphylococcal vaccine 56 NASDAQ LGND 56 Lenocta 56 sodium Injection 56 Predictive medicine 56 Alnylam RNAi 56 LHRH antagonist 56 PDE# inhibitors 56 oral nucleoside analogue 56 HepeX B 56 ALN VSP Phase 56 Aganocide ® 56 Qualified Therapeutic Discovery 56 platform HDL Mimetic 56 proprietary phage display 56 Oxxon 56 TSX ONY 56 pathophysiological effects 56 Cyclosert TM 56 immunotherapeutic vaccine 56 www.ucb group.com 56 commercialize OncoGenex lead 56 RECOTHROM R 56 RNAi therapeutic 56 ARCALYST R 56 Ocrelizumab 56 Elagolix 56 mGluR2 positive 56 transthyretin TTR 56 Anticalin R 56 monoclonal antibody therapeutics 56 biodefense pathogens 56 EGEN 56 Arno Therapeutics 56 ProMune 56 Alligator Bioscience AB 56 pan HDAC inhibitor 56 CRTH2 56 BHT DNA 56 R MSCRAMM 56 NS5B polymerase 56 Luveris R Ovidrel R 56 XL# XL# XL# 56 acyclovir Lauriad R 56 Ostarine ™ 56 immunotoxin 56 siRNA therapeutics 56 candidate ATHX 56 R roscovitine 56 Liprotamase 56 Fc engineered 56 Euroscreen 56 NASDAQ CRXL 56 ThermoDox ® clinical 56 erlotinib Tarceva ® 56 Ono Pharmaceutical 56 catalytic antioxidant compounds 56 humanised antibody 56 OTC BB PVCT http:/www.pvct.com 56 Nippon Kayaku 56 Juvaris 56 Nasdaq IDRA 56 SansRosa 56 Oral NKTR 56 histone deacetylase HDAC inhibitor 56 Albuferon TM 56 JCR Pharmaceuticals 56 EpiTherapeutics 56 Fibrosis Foundation Therapeutics 56 Tesetaxel 56 Asentar TM 56 Novartis NVS Snapshot Report 56 Personalized Immunotherapy 56 Panzem NCD 56 sorafenib tablets small 56 CYT# vascular disrupting 56 Panzem R NCD 56 collaborator Genentech 56 ImQuest 56 highly selective adenosine 56 rALLy clinical trial 56 5 HT3 antagonist 56 Naglazyme R 56 Panzem R 56 ofatumumab HuMax CD# 56 humanized antibodies 56 Nasdaq ENZN 56 Nasdaq RXII 56 evaluating satraplatin 56 Creabilis Therapeutics 56 CDP# 56 Genasense ® 56 Oncaspar 56 Elusys 56 Nasdaq RDEA 56 CTA# Injection 56 CEQ# 56 Virosome Biologicals 56 ALTROPANE R 56 selective androgen receptor modulators 56 Archexin 56 HuCNS SC ® 56 AnGes MG Inc. 56 Inc. NASDAQ ZLCS 56 GLP1 INT TM 56 OTCBB NRGX 56 telomerase inhibitor 56 ACLARA 56 Juvaris BioTherapeutics 56 antisense inhibitors 56 ARIUS 56 sulfonylhydrazine class 56 siRNA therapeutic 56 Apaziquone 56 Alder Biopharmaceuticals Inc. 56 neratinib 56 Amarantus 56 commercialize SGN 56 HuCAL PLATINUM R 56 Adenosine A2A 56 GTC NASDAQ GTCB 56 Rigel R# 56 Onalta ™ 56 romazarit 56 Sphingomab 56 Nasdaq IMGN 56 RELOVAIR ™ 56 Bioral ® 56 fusion inhibitor 56 Proxinium TM 56 collagen sponge seeded 56 TLR9 agonists 56 Survivin antagonist 56 R rilonacept Injection 56 Dicer Substrate Technology 56 Omeros Corporation 56 PRNewswire FirstCall Pharmasset 56 photodynamic therapy dermatology 56 Ofatumumab 56 Urocidin TM 56 HyACT 56 vinorelbine emulsion 56 Quinamed 56 DCVax R 56 enhanced skin permeation 56 Response Genetics Inc. 56 proprietary radiolabeled monoclonal 56 ApoB SNALP 56 ViroChem 56 oral dual endothelin 56 polymerase inhibitors 56 Tobira Therapeutics 56 acetonide FA 56 RECOTHROM ® 56 DURECT proprietary 56 potently inhibit 56 OncoGenex Pharmaceuticals Inc. 56 Metabasis Therapeutics Inc. 56 IRX 2 56 HER2 ErbB2 56 Plexxikon 56 HepDirect R 56 Syntonix 56 Inc. Nasdaq MITI 56 Nasdaq SGEN 56 Spiegelmer ® 56 Locteron combines 56 Thiovir 56 Initiates Phase II 56 Phase IIa trials 56 PEGylated Fab fragment 56 pediatric acute lymphoblastic 56 ZFP Therapeutic ® 56 OctoPlus licensed 56 Annamycin 56 Lung Rx 56 Hybridon 56 Ozarelix 56 ASONEP TM 56 Onconase 56 ErbB3 56 CEA CD# Her2 56 Bayer HealthCare Onyx Pharmaceuticals 56 nitric oxide donating 56 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 56 OTCBB URGP specialty 56 Helix BioMedix Inc. 56 ZK EPO 56 thetreatment 56 subsidiaries visit http:/www.apricusbio.com 56 Alocrest 56 orally dosed 56 Chimigen TM 56 Xoma Ltd 56 Nasdaq RGEN 56 Epidermal Growth Factor Receptor 56 RiVax ™ 56 Velcade bortezomib 56 LHRH receptor positive 56 TLR agonists 56 Crucell NV NYSE Euronext 56 Nasdaq EPCT 56 DsiRNA 56 memantine HCl 56 Bexion 56 GV# [001] 56 HER1 56 technology visit http:/www.genmab.com 56 InterfeRx 56 FoldRx Pharmaceuticals Inc. 56 Pancreate 55 deforolimus 55 Azedra 55 signal transduction inhibitors 55 Inc. NASDAQ SGEN 55 Prochymal TM 55 elotuzumab 55 cardio metabolic diseases 55 5 HT4 55 selective estrogen receptor modulator 55 LGLS 55 GRNOPC1 contains 55 Aurora kinase 55 HCV nucleotide polymerase inhibitor 55 please visit http:/www.vandapharma.com 55 Combivir Kivexa 55 testing huN# DM1 55 selectin antagonist 55 EP #R 55 Amplimmune 55 JOULFERON 55 ViiV Healthcare 55 AN# topical anti 55 novel anti infective 55 pipeline ImmunoGen collaborators 55 YM AIM YMBA 55 Viamet 55 novel synthetic PEGylated 55 IMPDH inhibitor 55 Nasdaq VRTX 55 metastatic colorectal 55 Kahalalide F 55 RTP #i 55 GVAX cancer 55 Imprime PGG ® 55 Adnectin 55 Salmedix 55 Oracea TM 55 Zenyaku Kogyo 55 Nasdaq ISIS 55 Enhanze 55 Ercole Biotech 55 RNA interference RNAi therapeutics 55 Agonist MABA program 55 cutaneous T 55 highly selective inhibitor 55 VisEn Medical 55 visit http:/www.mannkindcorp.com 55 Pentad TM 55 ProLindac TM 55 metastatic castration resistant 55 BiTE 55 factor TNF receptor 55 Nasdaq VICL 55 REGENERX BIOPHARMACEUTICALS INC. 55 Inc. Nasdaq PPHM 55 oral deforolimus 55 SGLT Inhibitors 55 Merck Serono Nycomed 55 affiliate Evogene Ltd. TASE 55 secretory phospholipase A2 sPLA2 55 trastuzumab emtansine T DM1 55 BCG refractory carcinoma 55 BY WILLA J. 55 Agios Pharmaceuticals 55 pulmonology portfolio 55 Sym# 55 visit biotech.com 55 eniluracil 55 TSX TKM 55 Initiate Clinical Trial 55 fatty acid amide hydrolase 55 relapsed multiple myeloma 55 PRNewswire FirstCall Monogram Biosciences 55 NXL# 55 5 HT2A serotonin 55 DP VPA 55 KNS # 55 TRAIL receptor antibodies 55 include PLX IBD 55 Cerimon Pharmaceuticals Inc. 55 Astex Therapeutics 55 phase IIb clinical 55 lumiliximab 55 PDX pralatrexate 55 cardio renal 55 Nautilus Biotech 55 DNA methyltransferase inhibitors 55 class mGluR5 inhibitor 55 triggers apoptosis programmed 55 antisense drugs 55 Trubion Pharma 55 #D#C# 55 metastatic hormone refractory 55 CR# vcMMAE